TRANSITIONS BUPRENORPHINE CLINIC OF SACRAMENTO (EIN 853034871) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Phone

9164521068

Tax Period

2024-01-01 to 2024-12-31

TRANSITIONS BUPRENORPHINE CLINIC OF SACRAMENTO, founded in 2021, is a community nonprofit in the Health Care sector that reported $2.1M in total revenue in fiscal year 2024. The organization ran a surplus of $665K, a strong 31% operating margin.

Mission

TRANSITIONS BUPRENORPHINE CLINIC OF SACRAMENTO IS DEDICATED TO PROVIDING EQUAL ACCESS TO MEDICATIONS FOR ADDICTION TREATMENT. WE ARE AN OUTPATIENT TREATMENT CENTER THAT PROVIDES LOW BARRIER TREATMENT FOR SUBSTANCE USE DISORDERS INCLUDING OPIATE, STIMULANT, ALCOHOL AND NICOTINE USE DISORDERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $455,773

Program Service Revenue $1,672,335

Investment Income $0

Other Revenue $0

TOTAL REVENUE $2,128,108

Expense Breakdown

Grants Paid $0

Salaries & Benefits $380,688

Fundraising Expenses $0

Program Expenses $1,160,513

Other Expenses $1,082,048

TOTAL EXPENSES $1,462,736

Year-over-Year Comparison

	2024	2023	Change
Revenue	$2,128,108	N/A	N/A
Expenses	$1,462,736	N/A	N/A
Net Income	$665,372	N/A	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$44,352

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LIANE BRUCKSTEIN	Executive Dir.	40.00	Officer	$44,352	$0	$44,352
SHERRY WILLIAMS	President	1.00	Director	$0	$0	$0
WILL CREGER	Treasurer	1.00	Director	$0	$0	$0
SANDRA BOYKIN	MEMBER	1.00	Director	$0	$0	$0
LYNELL CLANCY	Secretary	1.00	Director	$0	$0	$0
MAURICE CONNER	MEMBER	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$2,128,108	$1,462,736	$595,372	$665,372

TRANSITIONS BUPRENORPHINE CLINIC OF SACRAMENTO